Drug Development

Synergistic partnership drives creation of unique range of flexible, scalable services to help accelerate and de-risk drug development

Novel platform initially focused on high-resolution industrial scale processing of therapeutic mRNA

Byproduct of bacteria that help shipworms digest the wood they eat has been proven to kill causal parasites for some of the world's most common infections

Lilly Innovation Development Center takes home Excellence in Innovation Award

Chromatrap® ChIP kits deliver fast workflow, enabling users to process up to 96 ChIP assays simultaneously in just one day

Scientists found that baloxavir dramatically reduced the time someone with the flu is contagious for, suggesting a similar drug should be prioritized for COVID-19 treatment

Partnership will enable drug developers and quality control laboratories to take full advantage of the power of the monocyte activation test

Research findings pave the way toward the mass production of purer, cheaper, and safer drugs that can be made in a scalable and more environmentally-friendly way

Researchers have developed a new method that identifies double-bridged peptides that bind a disease target of interest and survive enzymes of the gastrointestinal tract

Researchers from DTU have revealed the structure of an enzyme that can convert low-cost sugars into hard-to-produce alpha-GalNAc sugars with therapeutic properties